Manufacturing, Recombinant Proteins

Continuous Processing for Viral Vectors

August 01, 2022

Manufacturers are taking the first steps toward process intensification.

MilliporeSigma’s ZooMAb Antibodies Earn ACT Label from My Green Lab

May 09, 2022

MilliporeSigma’s ZooMAb antibodies have been recognized for their low environmental impact by My Green Lab.

What’s New in Downstream Processing?

April 01, 2022

The past year of downstream processing has brought innovations in pH sensitive antibody purification, single-use fermentation separators, and more.

Thermo Fisher Scientific Opens Biologics Manufacturing Site in Lengnau, Switzerland

October 04, 2021

Thermo Fisher’s new Swiss facility will initially produce CSL Limited’s recombinant factor IX product Idelvion.

BioVaxys and WuXi to Collaborate on SARS-CoV-2 S-Protein Production

March 15, 2021

WuXi will produce SARS-CoV-2 s-proteins for BioVaxys’ COVID-19 vaccine candidate, BVX-0320, and for its Covid-T immunodiagnostic program.

Novavax Expands COVID-19 Collaboration and License Agreement with SK Bioscience

February 17, 2021

The companies have expanded their existing partnership to include 40 Million Doses of COVID-19 vaccine for South Korea.

NSERC Awards Alliance Grant to PlantForm to Enable Commercial-Scale Production of Protein Therapeutics

December 02, 2020

The grant will support the advancement of glycoengineering technology for plant-derived proteins developed by a University of Alberta scientist partnered with PlantForm.

AGC Biologics Adds Mammalian Production Capacity in Japan

October 11, 2018

The new facility will include comprehensive mammalian process development and manufacturing capabilities.

The Challenge of Disruptive Technologies in Bioprocessing

July 01, 2018

Increasing demand for biologics is driving the need for innovation in bioprocessing.

Amgen to Build Next-Generation Biomanufacturing Plant

April 11, 2018

The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.